Investor Relations

Press Release

July 24, 2017

Amphastar Announces Jury Verdict in Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.

More
June 1, 2017

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

More
May 10, 2017

Amphastar Pharmaceuticals to Present at the 20th Annual Bank of America Merrill Lynch Health Care Conference

More
May 8, 2017

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017

More
May 4, 2017

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on May 8, 2017

More
March 31, 2017

Amphastar Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference

More
March 13, 2017

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2016

More
March 9, 2017

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 13, 2017

More
February 21, 2017

Amphastar Announces the Receipt of a CRL for Intranasal Naloxone for the Emergency Treatment of Opioid Overdose

More
December 27, 2016

Amphastar Pharmaceuticals Receives Complete Response Letter for Primatene® Mist

More
Youtube